<?xml version="1.0" encoding="UTF-8"?>
<p>COVID-19 has raised various concerns among patients on chronic immunosuppressive therapy because the immune response to the virus was thought to be lowered. This has created a concern for possible non-adherence to these medications. Immunosuppressive agents are known to impair immune function, thereby increasing the risk of any infection. However, it has been described that uncontrolled disease activity in patients with rheumatoid arthritis and SLE puts them at a significantly higher risk for outpatient infections and hospitalization [
 <xref rid="R69" ref-type="bibr">69</xref>, 
 <xref rid="R70" ref-type="bibr">70</xref>]. It is of utmost importance to optimize patient medication adherence to prevent any discontinuation of chronic treatment, which may lead to disease flare and increased risk of infection [
 <xref rid="R71" ref-type="bibr">71</xref>].
</p>
